Bacterial biofilms in the upper airway - evidence for role in pathology and implications for treatment of otitis media.
about
Classification, identification, and clinical significance of Haemophilus and Aggregatibacter species with host specificity for humansAcute otitis media with spontaneous tympanic membrane perforation.Identification of Poly-N-acetylglucosamine as a Major Polysaccharide Component of the Bacillus subtilis Biofilm MatrixFrom in vitro to in vivo Models of Bacterial Biofilm-Related Infections.New paradigms in the pathogenesis of otitis media in childrenMoraxella catarrhalis uses a twin-arginine translocation system to secrete the β-lactamase BRO-2.Haemophilus responses to nutritional immunity: epigenetic and morphological contribution to biofilm architecture, invasion, persistence and disease severity.Moraxella catarrhalis is susceptible to antimicrobial photodynamic therapy with Photofrin.Vaccines for Nontypeable Haemophilus influenzae: the Future Is Now.Antibodies against the majority subunit of type IV Pili disperse nontypeable Haemophilus influenzae biofilms in a LuxS-dependent manner and confer therapeutic resolution of experimental otitis media.Haemophilus influenzae biofilm formation in chronic otitis media with effusion.Antibiotic Treatment for First Episode of Acute Otitis Media Is Not Associated with Future RecurrencesManagement of acute otitis media in children six months of age and olderDirected vaccination against pneumococcal disease.In situ pneumococcal vaccine production and delivery through a hybrid biological-biomaterial vector.Improvement rate of acute otitis media caused by Haemophilus influenzae at 1 week is significantly associated with time to recovery.Persistent and Recurrent Bacterial Bronchitis-A Paradigm Shift in Our Understanding of Chronic Respiratory Disease.Vaccines for children and adults with chronic lung disease: efficacy against acute exacerbations.Role of biofilm in children with recurrent upper respiratory tract infections.Antimicrobial activity of antisense peptide-peptide nucleic acid conjugates against non-typeable Haemophilus influenzae in planktonic and biofilm forms.Recognition and management of children with protracted bacterial bronchitis.Incorporation of phosphorylcholine into the lipooligosaccharide of nontypeable Haemophilus influenzae does not correlate with the level of biofilm formation in vitro.Identification of biofilms in post-tympanostomy tube otorrhea.Low Concentrations of Nitric Oxide Modulate Streptococcus pneumoniae Biofilm Metabolism and Antibiotic Tolerance.A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: an update on current progress and challenges.A Cation-binding Surface Protein as a Vaccine Antigen to Prevent Moraxella catarrhalis Otitis Media and Infections in Chronic Obstructive Pulmonary Disease.Insights on persistent airway infection by non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease.Type IV Pilus Expression Is Upregulated in Nontypeable Haemophilus influenzae Biofilms Formed at the Temperature of the Human Nasopharynx.[Bacteriologic investigation of the Eustachian tube and the implications of perioperative antibiotics before balloon dilation].Nontypeable Haemophilus influenzae releases DNA and DNABII proteins via a T4SS-like complex and ComE of the type IV pilus machinery.La prise en charge de l’otite moyenne aiguë chez les enfants de six mois et plus.Comprehensive vaccine design for commensal disease progression.Otitis media with effusion and atopy: is there a causal relationship?Extracellular DNA and Type IV Pilus Expression Regulate the Structure and Kinetics of Biofilm Formation by Nontypeable Haemophilus influenzae.The DNABII family of proteins is comprised of the only nucleoid associated proteins required for nontypeable Haemophilus influenzae biofilm structure.
P2860
Q24567783-3D3ACE86-A3C3-4EA5-9EE2-5E4FDE5BD8D0Q30245071-72849138-530D-45A1-AD70-DBE96C059C9EQ30375706-8955BB23-8150-43B5-A4A4-C21C48005097Q30424697-0F4E6835-8912-401C-841B-36D18690E97FQ30444709-1A1BEA60-7B76-4CA3-9D20-ED43A741A8F1Q34778118-84EBEFEA-E2D1-4116-B0BF-1542FDB90D31Q35018104-D5B5C1DC-9EA0-4FC1-91D6-ECB4C08778B7Q35231187-620D0D2E-9DDC-42E2-B19A-4BEE8F7845CDQ35548019-68138053-6EF2-4789-97E5-DA2038890A3CQ35579952-24D719B8-D05B-4479-A566-E180606257DEQ35946758-CA0BDEF8-D0B2-4536-9643-4A231C299FE5Q36134558-D31CA228-1D79-40D5-AE96-E93209679A2FQ36592918-68029C62-55A7-4ACA-8781-9353F1244A35Q37040681-A06F1AB9-9A8C-40C3-880F-80F9D03CA5F4Q37088578-AA1FE831-2FF1-4766-80FF-453C3B1EF46BQ37470304-570EDF13-EED7-4C1D-ACB2-4BCCC4094404Q37642024-97895BB2-DA91-4E00-B223-467D952847AEQ38168915-53DE7619-997C-47FA-A49A-F3468525152BQ38260524-D5EBB896-BA89-4F9C-8D56-717B9B58B5DAQ38289742-53B625ED-F380-4C16-B285-B3C50F84FDD9Q38542424-E50ED4E4-F13A-427B-82A3-760E79D9F9CCQ38851861-79CB742D-3802-4EE2-9AD3-619EF00E783EQ38900105-6108C2C9-7180-4C9E-9035-278B25169EEEQ39515768-51B499FA-969A-4945-97A0-A7476B57C2FEQ40074756-807FA72E-D109-444B-9625-839554E33478Q40154497-4486055E-E57F-47E3-B991-EEA7787DC532Q40235118-D7DBEF19-3A34-4DCD-BCED-65716D341B26Q40728738-4025D26A-908B-41F7-A352-60319BE50A70Q41035681-3493DF12-B72B-443F-9C6C-E3F5B166C867Q41433550-F7186EC9-12A6-4993-8085-3EF6C675DC39Q46913156-53797D09-C645-4C32-AA6F-3C7BD04FE0D2Q47094231-BD8BCA71-C4A4-4691-B2EC-74F83AD4E52AQ47100552-4BE7377F-A113-4973-99F5-8F1E520FDA1FQ47138997-D0406251-DCDF-44FA-856B-12C341F306B9Q47303593-1BC82CA9-CC6D-4B8C-8805-7249A86A2454
P2860
Bacterial biofilms in the upper airway - evidence for role in pathology and implications for treatment of otitis media.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Bacterial biofilms in the uppe ...... for treatment of otitis media.
@en
type
label
Bacterial biofilms in the uppe ...... for treatment of otitis media.
@en
prefLabel
Bacterial biofilms in the uppe ...... for treatment of otitis media.
@en
P2860
P1476
Bacterial biofilms in the uppe ...... for treatment of otitis media.
@en
P2860
P304
P356
10.1016/J.PRRV.2012.03.001
P577
2012-05-27T00:00:00Z